Dr. Eyal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1700 Center St
Mobile, AL 36604Phone+1 251-415-1055Fax+1 251-415-1045
Education & Training
- University of TennesseeResidency, Pediatrics, 1973 - 1974
- The Hebrew University of Jerusalem Hadassah Medical SchoolClass of 1969
Certifications & Licensure
- AL State Medical License 1995 - 2024
- MD State Medical License 1986 - 1996
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Neonatal-Perinatal Medicine
Clinical Trials
- Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity Start of enrollment: 2005 Nov 01
- Evaluation of a Standard Preterm Infant Formula Fed to Preterm Infants in the Hospital Start of enrollment: 2012 Nov 01
- Randomized Controlled Trial to Evaluate the Safety and Efficacy of Acetaminophen in Preterm Infants Used in Combination With Ibuprofen for Closure of the Ductus Arteriosus Start of enrollment: 2018 Dec 15
Publications & Presentations
PubMed
- 20 citationsReducing antibiotic utilization rate in preterm infants: a quality improvement initiative.Ramachandra Bhat, Haidee Custodio, Cathy McCurley, Richard M Whitehurst, Rashmi Gulati
Journal of Perinatology. 2018-02-02 - 98 citationsLocalized intestinal perforations after enteral administration of indomethacin in premature infantsGad Alpan, Fabien G. Eyal, I. Vinograd, R. Udassin, G. Amir
The Journal of Pediatrics. 1985-02-01 - 137 citationsTRPV4 channels augment macrophage activation and ventilator-induced lung injury.Kazutoshi Hamanaka, Ming-Yuan Jian, Mary I. Townsley, Judy A. King, Wolfgang Liedtke
American Journal of Physiology. Lung Cellular and Molecular Physiology. 2010-06-18
Press Mentions
- rhIGF-1/rhIGFBP-3 in Preterm Infants: A Phase 2 Randomized Controlled TrialMarch 1st, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: